Page last updated: 2024-08-16
sodium tetradecyl sulfate and Hepatocellular Carcinoma
sodium tetradecyl sulfate has been researched along with Hepatocellular Carcinoma in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chan, FK; Chung, SC; Johnson, PJ; Lee, YT; Suen, R; Sung, JJ; Yeo, W | 1 |
Trials
1 trial(s) available for sodium tetradecyl sulfate and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate.
Topics: Carcinoma, Hepatocellular; Cyanoacrylates; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Prognosis; Prospective Studies; Recurrence; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Survival Rate; Thrombosis | 1998 |